Falling folic acid supplement uptake threatens progress on children's health, experts warn
Declining use of folic acid supplements before pregnancy is undermining progress in preventing serious birth defects, health experts say.
Aug 10, 2026
0
4
Heterocyclic Compounds: News and Research on Heterocyclic Compounds
MeSH tree: D03
Protective drug dexrazoxane reduces heart damage in pediatric cancer survivors years after treatment ends
A new study reveals that the cardioprotective drug dexrazoxane significantly reduces heart damage caused by chemotherapy in pediatric cancer patients 15 years or more after treatment ends.
Aug 7, 2026
0
9
Q&A: Medicare spending on clinical care for people aging with HIV projected to rise steeply over next decade
As more Americans with HIV live into older age, Medicare spending on their care is projected to rise dramatically from $10.9 billion in 2026 to $27.3 billion in 2035, with HIV medications accounting for nearly two-thirds ...
Aug 7, 2026
0
3
Household hums below hearing range damage mouse kidneys in five-day experiment
Previous studies have hinted that people surrounded by more environmental noise—low, deep rumblings from air-conditioning units, elevator motors, distant traffic and ventilation ducts—tend to have worse kidney function. But ...
Aug 7, 2026
0
230
Expert shares practical tips for treating hair loss
Hair loss is often caused by a combination of heredity and aging, says Dr. Dawn Davis, a Mayo Clinic dermatologist. Treatments that may slow that type of hair loss and help regrow hair, including over-the-counter therapies ...
Aug 7, 2026
0
195
Why the same antibiotic can cure one infection but fail in another
A group of researchers has uncovered why one common antibiotic works for urinary tract infections but often fails elsewhere, offering greater insight into how the body's own chemistry can determine whether antibiotics succeed ...
Aug 6, 2026
0
8
Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial
The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is ...
Aug 6, 2026
0
9
GLP-1 drug linked to heart benefits for high-risk patients
Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...
Aug 5, 2026
0
7
New psychedelic candidate may spare the gut while still healing the brain
Psychedelic drugs are best known for altering perception and producing vivid hallucinations, but scientists are increasingly interested in what else they might do. A growing body of research suggests that these mind-altering ...
First-in-class small molecule inhibitor shows promise against pancreatic cancer in preclinical studies
Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ domain of the GIPC1 protein, which helps different types of cancer, including pancreatic ...
Aug 5, 2026
0
35
